{"id":26006,"date":"2023-05-12T12:35:25","date_gmt":"2023-05-12T10:35:25","guid":{"rendered":"https:\/\/d36deud6t4mnhi.cloudfront.net\/investisseurs\/material-announcement\/"},"modified":"2025-08-08T08:17:57","modified_gmt":"2025-08-08T06:17:57","slug":"material-announcement","status":"publish","type":"page","link":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/","title":{"rendered":"Actualit\u00e9s corporate"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/08\/08075744\/Investors-Corporate-News.jpg)\">\n        <div class=\"container content-sec\" role=\"main\" id=\"main\">\n            <nav aria-label=\"breadcrumb\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/\">Accueil<\/a><\/li><li class=\"breadcrumb-item visible\"><a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/\">Investisseurs<\/a><\/li><li class=\"breadcrumb-item active\"><a class=\"link-pointer-events-none\" href=\"#\" aria-current=\"page\">Actualit\u00e9s corporate<\/a><\/li><\/ol>\n            <\/nav>            <h1 class=\"visible\">Actualit\u00e9s corporate<\/h1>\n            <p class=\"visible\"><\/p>\n        <\/div>\n    <\/section>\n\n\n\n<section class=\"media-tabs\">\n      <div class=\"container\">\n        <div class=\"media-tabs-inner\">\n          <ul class=\"media-list-ul\">\n                              <li class=\"media-list-items\">\n                      <a class=\"media-item-link \" href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/resultats-financiers\/\">R\u00e9sultats financiers<\/a>\n                  <\/li>\n                              <li class=\"media-list-items\">\n                      <a class=\"media-item-link active\" href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/\">Actualit\u00e9s corporate<\/a>\n                  <\/li>\n                              <li class=\"media-list-items\">\n                      <a class=\"media-item-link \" href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/calendrier-financier\/\">Calendrier financier<\/a>\n                  <\/li>\n                              <li class=\"media-list-items\">\n                      <a class=\"media-item-link \" href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/evenements-investisseurs\/\">\u00c9v\u00e9nements investisseurs<\/a>\n                  <\/li>\n                              <li class=\"media-list-items\">\n                      <a class=\"media-item-link \" href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/rapports-et-comptes\/\">Rapports et autres documents<\/a>\n                  <\/li>\n                      <\/ul>\n          <div id=\"navTabArrows\">\n              <div class=\"tab-nav-arrows\" id=\"tab-nav-prev\"><\/div>\n              <div class=\"tab-nav-arrows\" id=\"tab-nav-next\"><\/div>\n          <\/div>\n        <\/div>\n      <\/div>\n<\/section>\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:75%\">\n<section class=\"media-filter\">\n    <div class=\"container media-filter-inner\">\n                <div class=\"media-filter-main\" id=\"search-total-div\" data-langaugecode=\"fr\" data-paginationtype=\"visible\" data-loadmore=\"hidden\" data-filtertype=\"material-announcement\" data-posttype=\"press_release\"\n            data-pagination=\"visible\" data-parenttermid=\"[9900,3555,3562,9904,3539]\">\n            <div class=\"row\">\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                                        <!-- media drop down -->\n                    <div class=\"media-drop-down\">\n                        <p class=\"media-drop-heading\">Filtre<\/p>\n                        <div class=\"media-dropdown-items\">\n                            <div class=\"row\">\n                                                                                                                            <div class=\"column-2 col-lg-4 col-md-4 col-sm-12\">\n                                    <div class=\"period-filter\">\n                                            <p>P\u00e9riode<\/p>\n                                          <div class=\"mutltiselect-dropdown year-dropdown\" role=\"searchbox\" aria-label=\"P\u00e9riode\">\n                                            <select name=\"langOpt[]\" multiple id=\"periodOpt\">\n                                                                                            <option value=\"2025\">2025                                                                                            <option value=\"2024\">2024                                                                                            <option value=\"2023\">2023                                                                                            <option value=\"2022\">2022                                                                                            <option value=\"2021\">2021                                                                                            <option value=\"2020\">2020                                                                                            <option value=\"2019\">2019                                                                                            <option value=\"2018\">2018                                                                                            <option value=\"2017\">2017                                                                                            <option value=\"2016\">2016                                                                                        <\/select>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                                \n                                                                                                            <div class=\"column-3 col-lg-4 col-md-4 \">\n                                            <div class=\"filterby-filter\">\n                                                <p>Filtrer par<\/p>\n                                                <div class=\"input-filter\" tabindex=\"0\" role=\"searchbox\" aria-label=\"Filtrer par\">\n                                                    <input type=\"search\" name=\"filter-by\" id=\"filter-by\"\n                                                        placeholder=\"Taper un mot cl\u00e9\" >\n                                                <\/div>\n                                                <div class=\"filter-by-dropdown\">\n                                                    <p class=\"recent\">recherche r\u00e9cente<\/p>\n                                                                                                        <ul class=\"filter-by-list\">\n                                                                                                            <\/ul>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                                                                                                              <\/div>\n                            <div class=\"reset-btn-div\">\n                                <a href=\"#\" class=\"reset-btn\">R\u00e9initialiser<\/a>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n                                        <!-- sorting section -->\n                    \t\t\t\t\t\t\n        <section class=\"media-filter\">\n            <div class=\"container media-filter-inner\">\n                <div class=\"media-filter-main\" id=\"search-total-div\" data-langaugecode=\"en\" data-paginationtype=\"visible\" data-loadmore=\"hidden\" data-filtertype=\"investor-event\" data-posttype=\"event\" data-pagination=\"visible\" data-parenttermid=\"[492,493,1810,494]\">\n                    <div class=\"row\">\n                        <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                        <div class=\"sorting-sec\">\n                            <div class=\"row\">\n                                                                    <div class=\"column-1 col-xl-6 col-lg-6 col-sm-12\">\n                                        <div class=\"no-of-item-sec\">\n                                            <p>Afficher: <span id=\"start-value\">1<\/span> &#8211; <span id=\"no-of-search\">05<\/span> de <span id=\"total-count\">18<\/span>\n                                                <\/p>\n                                        <\/div>\n                                    <\/div>\n                                                                <div class=\"column-2 col-xl-6 col-lg-6 col-sm-12\">\n                                                                            <div class=\"sort-input\">\n                                            <div class=\"sort-input-inner\">\n                                            <label for=\"sorting-input\">Afficher<\/label>\n                                                                                            <select name=\"order\" aria-label=\"show-list\" id=\"show-list\" tabindex=\"0\">\n                                                    <option value=\"05\" selected>05<\/option>\n                                                    <option value=\"10\" >10<\/option>\n                                                    <option value=\"20\" >20<\/option>\n                                                    <option value=\"30\" >30<\/option>\n                                                    <option value=\"40\" >40<\/option>\n                                                    <option value=\"50\" >50<\/option>\n                                                <\/select>\n                                            <\/div>\n                                        <\/div>\n\t\t\t\t\t\t\t\t\n                                                                                                                <div class=\"sort-input-ascending\">\n                                            <div class=\"sort-input-ascending-inner\">\n                                                <label for=\"sorting-input-ascend\">Trier par<\/label>\n                                                <select name=\"sorting-input-ascend\" id=\"show-list-as\" class=\"show-list-as\" tabindex=\"0\" aria-label=\"sorting\">\n                                                    <option value=\"DESC\" aria-label=\"Descendant\" selected>Descendant<\/option>\n                                                    <option value=\"ASC\" aria-label=\"Ascendant\"  >Ascendant<\/option>                                                    \n                                                <\/select>\n                                            <\/div>\n                                        <\/div>                                        \n                                                                    <\/div>\n                            <\/div>\n                        <\/div>\n                        <\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\n\t\t<\/section>\n                                       \n                    <!-- Search listing include start here-->\n                    <div id=\"search-results\" class=\"story-div\">\n                        <!-- Investors Material Announcement Listing start here -->\n<div class=\"story-div\" id=\"search-div\">\n    <div class=\"row story-row\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/ipsen-et-biomunex-annoncent-un-accord-de-licence-mondial-exclusif-pour-un-activateur-de-cellules-mait-une-nouvelle-classe-therapeutique-en-immuno-oncologie-2990251\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/05\/11132901\/PressRelease_FR.jpg\" alt=\"Ipsen et Biomunex annoncent un accord de licence mondial exclusif pour un activateur de cellules MAIT, une nouvelle classe th\u00e9rapeutique en immuno-oncologie\" title=\"Ipsen et Biomunex annoncent un accord de licence mondial exclusif pour un activateur de cellules MAIT, une nouvelle classe th\u00e9rapeutique en immuno-oncologie\"\/><\/a>\n\n                                    <\/div>\n           \n    <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#5d6265\">\n                        Corporate                    <\/button>\n                    <!-- <img decoding=\"async\" src=\"\"\n                        class=\"radio-img desk-span\" alt=\"\" srcset=\"\" width=\"auto\"> -->\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">03 d\u00e9cembre 2024                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">03 d\u00e9cembre 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                <a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/ipsen-et-biomunex-annoncent-un-accord-de-licence-mondial-exclusif-pour-un-activateur-de-cellules-mait-une-nouvelle-classe-therapeutique-en-immuno-oncologie-2990251\/\">\n                    <h5 class=\"blue-txt\">Ipsen et Biomunex annoncent un accord de licence mondial exclusif pour un activateur de cellules MAIT, une nouvelle classe th\u00e9rapeutique en immuno-oncologie<\/h5>\n                <\/a>\n                <p class=\"second-post-para\">PARIS (FRANCE), le 3\u00a0d\u00e9cembre\u00a02024 \u2013 Ipsen (Euronext\u00a0: IPN\u00a0; ADR\u00a0: IPSEY) et Biomunex\u00a0Pharmaceuticals annoncent aujourd\u2019hui la conclusion d\u2019un accord de licence mondial exclusif pour le programme BMX-502. Le BMX-502 est un anticorps bisp\u00e9cifique qui engage et active un sous-ensemble de cellules&#8230;<\/p>\n        <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n    <br><div class=\"row story-row\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                            <div class=\"video-embed\">\n                        <a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/testing-video-2\/\">\n                            <iframe loading=\"lazy\" title=\"Sample Video\" src=\"https:\/\/player.vimeo.com\/video\/347119375?app_id=122963&#038;autoplay=1&#038;muted=1&#038;controls=0&#038;loop=0&#038;autopause=1&#038;background=1\" width=\"640\" height=\"360\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" data-ot-ignore><\/iframe>                        <\/a>\n                    <\/div>\n                   \n    <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#5d6265\">\n                        Annonce                    <\/button>\n                    <!-- <img decoding=\"async\" src=\"\"\n                        class=\"radio-img desk-span\" alt=\"\" srcset=\"\" width=\"auto\"> -->\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">30 ao\u00fbt 2024                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">30 ao\u00fbt 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                                    <div class=\"story-share-sec visible\">\n                        <div class=\"share\"  data-title=\" Testing video 1\">\n                            <img decoding=\"async\" src=\"https:\/\/d14saept1n0koz.cloudfront.net\/wp-content\/themes\/ipsen-main\/dist\/images\/share-icon.svg\"\n                                alt=\"Partager sur les r\u00e9seaux sociaux\" title=\"Partager sur les r\u00e9seaux sociaux\"\/>\n                        <\/div>\n                        <div class=\"share-tray hidden\">\n                                                        <a href=\"https:\/\/www.linkedin.com\/shareArticle?url=https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/testing-video-2\/&#038;title=Testing video 1&#038;media=\">\n                                <img decoding=\"async\" src=\"https:\/\/d14saept1n0koz.cloudfront.net\/wp-content\/themes\/ipsen-main\/dist\/images\/LinkedIn.svg\" alt=\"Partager sur LinkedIn\" title=\"Partager sur LinkedIn\"\/>LinkedIn\n                            <\/a>\n                                                        <!--<a href=\"\">\n                                <img decoding=\"async\" src=\"\" alt=\"\" title=\" \"\/>Twitter\n                            <\/a> -->\n                                                        <a href=\"https:\/\/www.facebook.com\/sharer.php?u=https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/testing-video-2\/&#038;p=Testing video 1\">\n                                <img decoding=\"async\" src=\"https:\/\/d14saept1n0koz.cloudfront.net\/wp-content\/themes\/ipsen-main\/dist\/images\/Facebook.svg\" alt=\"Partager sur Facebook\" title=\"Partager sur Facebook\" \/>Facebook\n                            <\/a>\n                                                    <\/div>\n                    <\/div>\n                            <\/div>\n            <div class=\"story-post-content\">\n                <a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/testing-video-2\/\">\n                    <h5 class=\"blue-txt\">Testing video 1<\/h5>\n                <\/a>\n                <p class=\"second-post-para\">Lorem Ipsum&nbsp;is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry&rsquo;s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type&#8230;<\/p>\n        <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n    <br><div class=\"row story-row\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/ipsen-et-day-one-concluent-un-accord-exclusif-de-licence-hors-etats-unis-pour-commercialiser-le-tovorafenib-contre-la-forme-la-plus-courante-de-tumeur-cerebrale-chez-lenfant-2918482\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/05\/11132901\/PressRelease_FR.jpg\" alt=\"Ipsen et Day One concluent un accord exclusif de licence hors \u00c9tats-Unis pour commercialiser le tovoraf\u00e9nib contre la forme la plus courante de tumeur c\u00e9r\u00e9brale chez l\u2019enfant\" title=\"Ipsen et Day One concluent un accord exclusif de licence hors \u00c9tats-Unis pour commercialiser le tovoraf\u00e9nib contre la forme la plus courante de tumeur c\u00e9r\u00e9brale chez l\u2019enfant\"\/><\/a>\n\n                                    <\/div>\n           \n    <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#5d6265\">\n                        Corporate                    <\/button>\n                    <!-- <img decoding=\"async\" src=\"\"\n                        class=\"radio-img desk-span\" alt=\"\" srcset=\"\" width=\"auto\"> -->\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">25 juillet 2024                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">25 juillet 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                <a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/ipsen-et-day-one-concluent-un-accord-exclusif-de-licence-hors-etats-unis-pour-commercialiser-le-tovorafenib-contre-la-forme-la-plus-courante-de-tumeur-cerebrale-chez-lenfant-2918482\/\">\n                    <h5 class=\"blue-txt\">Ipsen et Day One concluent un accord exclusif de licence hors \u00c9tats-Unis pour commercialiser le tovoraf\u00e9nib contre la forme la plus courante de tumeur c\u00e9r\u00e9brale chez l\u2019enfant<\/h5>\n                <\/a>\n                <p class=\"second-post-para\">PARIS, FRANCE, et BRISBANE, CALIFORNIE \u00c9tats-Unis, le 25 juillet 2024 &#8211; Ipsen (Euronext : IPN\u00a0; ADR\u00a0: IPSEY) et Day One Biopharmaceuticals (Nasdaq : DAWN) (Day One), ont annonc\u00e9 aujourd\u2019hui la signature d\u2019un accord de partenariat mondial en dehors des \u00c9tats-Unis&#8230;<\/p>\n        <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n    <br><div class=\"row story-row\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/ipsen-et-foreseen-biotechnology-annoncent-la-signature-dun-accord-exclusif-de-licence-mondiale-pour-un-conjugue-anticorps-medicament-dote-dun-potentiel-de-premiere-classe-2911523\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/05\/11132901\/PressRelease_FR.jpg\" alt=\"Ipsen et Foreseen Biotechnology annoncent la signature d\u2019un accord exclusif de licence mondiale pour un conjugu\u00e9 anticorps-m\u00e9dicament dot\u00e9 d'un potentiel de premi\u00e8re classe\" title=\"Ipsen et Foreseen Biotechnology annoncent la signature d\u2019un accord exclusif de licence mondiale pour un conjugu\u00e9 anticorps-m\u00e9dicament dot\u00e9 d'un potentiel de premi\u00e8re classe\"\/><\/a>\n\n                                    <\/div>\n           \n    <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#5d6265\">\n                        Annonce                    <\/button>\n                    <!-- <img decoding=\"async\" src=\"\"\n                        class=\"radio-img desk-span\" alt=\"\" srcset=\"\" width=\"auto\"> -->\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">11 juillet 2024                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">11 juillet 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                <a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/ipsen-et-foreseen-biotechnology-annoncent-la-signature-dun-accord-exclusif-de-licence-mondiale-pour-un-conjugue-anticorps-medicament-dote-dun-potentiel-de-premiere-classe-2911523\/\">\n                    <h5 class=\"blue-txt\">Ipsen et Foreseen Biotechnology annoncent la signature d\u2019un accord exclusif de licence mondiale pour un conjugu\u00e9 anticorps-m\u00e9dicament dot\u00e9 d&rsquo;un potentiel de premi\u00e8re classe<\/h5>\n                <\/a>\n                <p class=\"second-post-para\">Paris (France) 11 juillet 2024 \u2013 Ipsen (Euronext\u00a0: IPN\u00a0; ADR\u00a0: IPSEY) et Foreseen Biotechnology (Foreseen) ont annonc\u00e9 aujourd\u2019hui la signature d\u2019un accord de licence mondial exclusif pour FS001, un conjugu\u00e9 anticorps-m\u00e9dicament (antibody-drug conjugate, ADC) potentiellement premier de sa classe th\u00e9rapeutique&#8230;.<\/p>\n        <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n    <br><div class=\"row story-row\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/ipsen-et-skyhawk-therapeutics-annoncent-la-signature-dun-accord-de-collaboration-de-recherche-visant-le-ciblage-darn-dans-les-maladies-neurologiques-rares-2866528\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/05\/11132901\/PressRelease_FR.jpg\" alt=\"Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d\u2019ARN dans les maladies neurologiques rares\" title=\"Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d\u2019ARN dans les maladies neurologiques rares\"\/><\/a>\n\n                                    <\/div>\n           \n    <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#5d6265\">\n                        Annonce                    <\/button>\n                    <!-- <img decoding=\"async\" src=\"\"\n                        class=\"radio-img desk-span\" alt=\"\" srcset=\"\" width=\"auto\"> -->\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">22 avril 2024                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">22 avril 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                <a href=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/press-releases\/ipsen-et-skyhawk-therapeutics-annoncent-la-signature-dun-accord-de-collaboration-de-recherche-visant-le-ciblage-darn-dans-les-maladies-neurologiques-rares-2866528\/\">\n                    <h5 class=\"blue-txt\">Ipsen et Skyhawk Therapeutics annoncent la signature d&rsquo;un accord de collaboration de recherche visant le ciblage d\u2019ARN dans les maladies neurologiques rares<\/h5>\n                <\/a>\n                <p class=\"second-post-para\">PARIS, FRANCE; BOSTON, \u00c9tats-Unis, le 22 avril 2024 &#8211; Ipsen (Euronext : IPN ; ADR : IPSEY) et Skyhawk Therapeutics ont annonc\u00e9 aujourd&rsquo;hui la signature d&rsquo;un accord de collaboration mondiale exclusive, visant la d\u00e9couverte et le d\u00e9veloppement de nouvelles petites&#8230;<\/p>\n        <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n    <br><div class=\"pagination\"><span class='page-numbers current'>1<\/span><a class='page-numbers' tabindex='0' onkeydown='paginationClick(2)' onclick='paginationClick(2)'>2<\/a><span class='page-numbers dots' tabindex='0'>&#8230;<\/span><a class='page-numbers' tabindex='0' onkeydown='paginationClick(4)' onclick='paginationClick(4)'>4<\/a><a class='next page-numbers' tabindex='0' onkeydown='paginationClick(2)' onclick='paginationClick(2)'><\/a><\/div><\/div>\n<!-- Investors Material Announcement Listing Ends here -->                        <!-- Search listing include end here-->\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:25%\">\n    <section class=\"side-panel contacts-card\">\n        <div class=\"container\">\n            <div class=\"side-media-contacts\">\n    <div class=\"media-contacts-head visible\">\n        <h6 class=\"contact-side heading-six\">\n            Vos contacts d\u00e9di\u00e9s        <\/h6>\n    <\/div>\n    <div class=\"media-contacts-list\">\n        <div class=\"main-media-contact-list\">\n                               <ul role=\"presentation\">\n                        <li>\n                            <h5 class=\"name-label visible\">Khalid Deojee<\/h5>\n                            <p class=\"designation-label\">Responsable Principal, Relations Investisseurs<\/p>\n                            <p class=\"designation-country visible\"><\/p>\n                        <\/li>\n                        <li class=\"parent-list\" role=\"presentation\">\n                          <ul role=\"presentation\"> \n                            \n                                                            <li>\n                                    <ul class=\"phone-child visible\" >\n                                        <li class=\"phone\"><img decoding=\"async\" src=\"https:\/\/d14saept1n0koz.cloudfront.net\/wp-content\/themes\/ipsen-main\/dist\/images\/Phone-Icon-New.svg\" alt=\"Num\u00e9ro de t\u00e9l\u00e9phone\"><\/li>\n                                        <li class=\"phone-number\" role=\"listitem\" aria-label=\"phone number\" ><a href=\"tel:+33 6 66 01 95 26\" id=\"user_phone\">+33 6 66 01 95 26<\/a><\/li>\n                                        <li class=\"copy-icon\" role=\"listitem\" aria-label=\"copy phone number\" tabindex=\"0\"><img decoding=\"async\" class=\"desktop-view\" data-value=\"+33 6 66 01 95 26\" src=\"https:\/\/d14saept1n0koz.cloudfront.net\/wp-content\/themes\/ipsen-main\/dist\/images\/Copy-Icon-New.svg\" alt=\"Copier le num\u00e9ro de t\u00e9l\u00e9phone\" title=\"Copier le num\u00e9ro de t\u00e9l\u00e9phone\" ><\/li>\n                                    <\/ul>\n                                <\/li>\n                            \n                              \n\n                                                            <li role=\"presentation\">\n                                    <ul role=\"list\" aria-label=\"email details\" class=\"email-child visible\">\n                                        <li class=\"email\" role=\"listitem\" aria-label=\"email icon\" tabindex=\"0\"><img decoding=\"async\" src=\"https:\/\/d14saept1n0koz.cloudfront.net\/wp-content\/themes\/ipsen-main\/dist\/images\/Mail-Icon-New.svg\" alt=\"Adresse e-mail\" title=\"Adresse e-mail\"><\/li>\n                                        <li class=\"email-id\" role=\"listitem\" aria-label=\"email id\"><a href=\"mailto:khalid.deojee@ipsen.com\" id=\"user_email\">khalid.deojee@ipsen.com<\/a><\/li>\n                                        <li class=\"copy-icon\" role=\"listitem\" aria-label=\"copy email id\" tabindex=\"0\"><img decoding=\"async\" class=\"desktop-view\" data-value=\"khalid.deojee@ipsen.com\" src=\"https:\/\/d14saept1n0koz.cloudfront.net\/wp-content\/themes\/ipsen-main\/dist\/images\/Copy-Icon-New.svg\" alt=\"Copier l'adresse e-mail\" title=\"Copier l'adresse e-mail\"><\/li>\n                                    <\/ul>\n                                <\/li>\n                            \n                                                      <\/ul>          \n                        <\/li>\n                                            <\/ul>\n\n                    <hr class=\"down-divider hidden\"> \n                                 \n        <\/div>\n\n        \n    <\/div>\n<\/div>        <\/div> \n    <\/section>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":195,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-26006","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen financial results<\/title>\n<meta name=\"description\" content=\"Learn about Ipsen\u2019s latest financial results; access historical financial data.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen financial results\" \/>\n<meta property=\"og:description\" content=\"Learn about Ipsen\u2019s latest financial results; access historical financial data.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-08T06:17:57+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/\",\"url\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/\",\"name\":\"Ipsen financial results\",\"isPartOf\":{\"@id\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#website\"},\"datePublished\":\"2023-05-12T10:35:25+00:00\",\"dateModified\":\"2025-08-08T06:17:57+00:00\",\"description\":\"Learn about Ipsen\u2019s latest financial results; access historical financial data.\",\"breadcrumb\":{\"@id\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investisseurs\",\"item\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s corporate\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#website\",\"url\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07154612\/Ipsen-logo_168x48-New3.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07154612\/Ipsen-logo_168x48-New3.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen financial results","description":"Learn about Ipsen\u2019s latest financial results; access historical financial data.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Ipsen financial results","og_description":"Learn about Ipsen\u2019s latest financial results; access historical financial data.","og_url":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/","og_site_name":"Global","article_modified_time":"2025-08-08T06:17:57+00:00","twitter_card":"summary_large_image","twitter_site":"@ipsengroup","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/","url":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/","name":"Ipsen financial results","isPartOf":{"@id":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#website"},"datePublished":"2023-05-12T10:35:25+00:00","dateModified":"2025-08-08T06:17:57+00:00","description":"Learn about Ipsen\u2019s latest financial results; access historical financial data.","breadcrumb":{"@id":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/material-announcement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/"},{"@type":"ListItem","position":2,"name":"Investisseurs","item":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/investisseurs\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s corporate"}]},{"@type":"WebSite","@id":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#website","url":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#organization","name":"IPSEN","url":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07154612\/Ipsen-logo_168x48-New3.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07154612\/Ipsen-logo_168x48-New3.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"_links":{"self":[{"href":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/wp-json\/wp\/v2\/pages\/26006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/wp-json\/wp\/v2\/comments?post=26006"}],"version-history":[{"count":31,"href":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/wp-json\/wp\/v2\/pages\/26006\/revisions"}],"predecessor-version":[{"id":81168,"href":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/wp-json\/wp\/v2\/pages\/26006\/revisions\/81168"}],"up":[{"embeddable":true,"href":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/wp-json\/wp\/v2\/pages\/195"}],"wp:attachment":[{"href":"https:\/\/d14saept1n0koz.cloudfront.net\/fr\/wp-json\/wp\/v2\/media?parent=26006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}